4/A

FORM 4/A SUBMISSION

Company: Lineage Cell Therapeutics, Inc.
Filed: November 3, 2010
Period of Report: October 27, 2010
Accession Number: 0001209191-10-053046

View Document ↗ View on SEC.gov ↗